相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S. Ireland et al.
CANCER CELL (2020)
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue
Brittany M. Bowman et al.
JOURNAL OF PATHOLOGY (2020)
A molecular map of lung neuroendocrine neoplasms
Aurelie A. G. Gabriel et al.
GIGASCIENCE (2020)
NRF2 Activation in Cancer: From DNA to Protein
Erica W. Cloer et al.
CANCER RESEARCH (2019)
Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids
Saurabh V. Laddha et al.
CANCER RESEARCH (2019)
Current Diagnosis and Management of Small-Cell Lung Cancer
Shuhang Wang et al.
MAYO CLINIC PROCEEDINGS (2019)
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
N. Alcala et al.
NATURE COMMUNICATIONS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?
Dmitriy Sonkin et al.
LUNG CANCER MANAGEMENT (2019)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Julie George et al.
NATURE COMMUNICATIONS (2018)
A catalogue of somatic NRF2 gain-of-function mutations in cancer
Michael John Kerins et al.
SCIENTIFIC REPORTS (2018)
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero et al.
NATURE MEDICINE (2017)
Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
Jung Han Kim et al.
ONCOTARGET (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Role of deltaNp63posCD44vpos cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas
Shotaro Yamano et al.
CANCER SCIENCE (2016)
Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma
Shiyong Li et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Clinical Implications of Genomic Discoveries in Lung Cancer
Charles Swanton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Classification and Pathology of Lung Cancer
Min Zheng
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options
Arpita Desai et al.
CANCER BIOLOGY & MEDICINE (2016)
Canonical Wnt Signaling Drives Tumor-Like Lesions from Sox2-Positive Precursors of the Murine Olfactory Epithelium
Nils W. Engel et al.
PLOS ONE (2016)
Of mice and men: olfactory neuroblastoma among animals and humans
A. Lubojemska et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2016)
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
David W. Cescon et al.
CLINICAL CANCER RESEARCH (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
David G. McFadden et al.
CELL (2014)
Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non-Small Cell Lung Cancer
Tatsushi Kodama et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
The 2015 WHO classification of lung tumors
W. D. Travis
PATHOLOGE (2014)
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Lynnette Fernandez-Cuesta et al.
NATURE COMMUNICATIONS (2014)
A simple and cost-effective method of DNA extraction from small formalin-fixed paraffin-embedded tissue for molecular oncologic testing
Anthony N. Snow et al.
BMC CLINICAL PATHOLOGY (2014)
The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
Holly K. Bryan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Emilia Kansanen et al.
REDOX BIOLOGY (2013)
Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
Natasha Rekhtman et al.
CLINICAL CANCER RESEARCH (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
Kate D. Sutherland et al.
CANCER CELL (2011)
Characterization of the cell of origin for small cell lung cancer
Kwon-Sik Park et al.
CELL CYCLE (2011)
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Gottfried E. Konecny et al.
CLINICAL CANCER RESEARCH (2011)
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Keiko Taguchi et al.
GENES TO CELLS (2011)
Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung Cancer
Frank McCaughan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: Fluorescence in situ hybridization and cytogenetic studies
Osman Demirhan et al.
CANCER EPIDEMIOLOGY (2010)
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Bethany E. Schaffer et al.
CANCER RESEARCH (2010)
Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Luisa M. Solis et al.
CLINICAL CANCER RESEARCH (2010)
Lung tumours with neuroendocrine differentiation
William D. Travis
EUROPEAN JOURNAL OF CANCER (2009)
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass et al.
NATURE GENETICS (2009)
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Anju Singh et al.
CANCER RESEARCH (2008)
Role of chromosome 3q amplification in lung cancer
Jun Qian et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Dual roles of Nrf2 in cancer
Alexandria Lau et al.
PHARMACOLOGICAL RESEARCH (2008)
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
Tatsuhiro Shibata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Mouse models incorporating alterations in the major tumor suppressor genes P53 and p16: Their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic agents
R Lubet et al.
EXPERIMENTAL LUNG RESEARCH (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays
MA Leversha et al.
JOURNAL OF PATHOLOGY (2003)
分享论文
